Nrx Pharmaceuticals
NRXP · NASDAQ · Health Care · Pharmaceutical Preparations
Pharmaceutical Preparations company based in Wilmington, De.
Example public filing
No filing stored for Nrx Pharmaceuticals in the last 12 months.
Nothing from insiders, Congress, funds or federal contracts dated in this period. See a real example on the home page, which shows live filings free.
On file for NRXP, last 12 months
- 1
- Insider filings
- 0
- Congress trades
- 0
- Fund positions
- 0
- Federal contracts
Records OQRO holds, counted by their date; a 13F position is counted once per quarter it is reported.
Insider buying and selling since 2017
Insiders of Nrx Pharmaceuticals reported 19 open-market purchases and 14 sales since 2017; purchases in 4 different years, most recently 2024.
| Year | Bought | Sold |
|---|---|---|
| 2024 | 1×1 trade | — |
| 2023 | 4×4 trades | — |
| 2022 | 13×13 trades | 10×10 trades |
| 2021 | — | 2×2 trades |
| 2020 | — | 1×1 trade |
| 2018 | — | 1×1 trade |
| 2017 | 1×1 trade | — |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. The amounts, the people and every filing are in OQRO Pro.
See the full picture with OQRO Pro.
1 record for Nrx Pharmaceuticals in the last 12 months, each linked to its filing. Full histories, the screener, alerts for the companies you follow and Ask OQRO.
Latest disclosures
Secure payment by Stripe. Renews every month until you cancel; cancel anytime from your account. No free trial.
Public previews are free. Full research requires Pro. No free trial.
What this page holds
- Insider trades and planned sales
- Politician trades (House and Senate)
- Fund holdings from 13F filings
- Federal contracts, lobbying and short selling
- Full history and context, with a link to every filing
What OQRO is
OQRO reads the public record for US-listed companies — insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings, and federal contract awards — and puts each one in plain words next to the filing it came from. It describes what was disclosed. It does not give investment advice or tell you what to buy.
Want to see real filings before you pay? The home page shows live ones, free, with the link to each source document.
Questions about Nrx Pharmaceuticals insider trading
Have Nrx Pharmaceuticals insiders bought shares recently?
No open-market purchase by an insider of Nrx Pharmaceuticals was filed in the last 90 days. The latest on record was on Dec 18, 2024.
How often do Nrx Pharmaceuticals insiders buy and sell shares?
Since 2017, Nrx Pharmaceuticals insiders reported 19 open-market purchases and 14 sales on Forms 4 and 5, with purchases in 4 different years, most recently 2024.
Do members of Congress trade NRXP?
No trade in Nrx Pharmaceuticals (NRXP) was disclosed by a member of Congress in the last 12 months.
When does Nrx Pharmaceuticals report its next results?
Nrx Pharmaceuticals's next results are expected on Nov 16, 2026. The date can move until the company confirms it. Insiders often trade in the weeks right after results.
Where does this data come from?
From official filings only: SEC Forms 4, 5 and 144 for insiders, House and Senate periodic transaction reports for Congress, SEC Form 13F for funds, Form 8-K for company events and USAspending for federal contracts. Every record on OQRO links to its source. It is public data, not investment advice.